Literature DB >> 23303157

Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation?

Angelita Habr-Gama1, Joaquim Gama-Rodrigues, Rodrigo Oliva Perez.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23303157     DOI: 10.1097/DCR.0b013e318277e8e4

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  8 in total

1.  The good, the bad and the ugly: rectal cancers in the twenty-first century.

Authors:  G P São Julião; A Habr-Gama; B B Vailati; R O Perez
Journal:  Tech Coloproctol       Date:  2017-06-19       Impact factor: 3.781

2.  Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: potential pitfalls of a multicentre observational study.

Authors:  R O Perez; A Habr-Gama; G P São Julião; B B Vailati
Journal:  Tech Coloproctol       Date:  2017-09-11       Impact factor: 3.781

3.  Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-25

Review 4.  Future directions for monitoring treatment response in colorectal cancer.

Authors:  Avery S Walker; Nathan P Zwintscher; Eric K Johnson; Justin A Maykel; Alexander Stojadinovic; Aviram Nissan; Itzhak Avital; Björn Ldm Brücher; Scott R Steele
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

5.  Quantitative Aspects of Diffusion-weighted Magnetic Resonance Imaging in Rectal Cancer Response to Neoadjuvant Therapy.

Authors:  Thiago Bassaneze; José Eduardo Gonçalves; Juliano Ferreira Faria; Rogério Tadeu Palma; Jaques Waisberg
Journal:  Radiol Oncol       Date:  2017-06-25       Impact factor: 2.991

6.  T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.

Authors:  Ian P Hayes; Elasma Milanzi; Rachel M Pelly; Peter Gibbs; Jeanette C Reece
Journal:  J Surg Oncol       Date:  2022-05-30       Impact factor: 2.885

Review 7.  Optimal Time Intervals between Pre-Operative Radiotherapy or Chemoradiotherapy and Surgery in Rectal Cancer?

Authors:  Bengt Glimelius
Journal:  Front Oncol       Date:  2014-04-07       Impact factor: 6.244

8.  Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer.

Authors:  Emma C Fields; Brian J Kaplan; Jeremy Karlin; Jennifer L Myers; Nitai Mukhopadhyay; Xiaoyan Deng; Heidi Sankala; Steven R Grossman; Khalid Matin
Journal:  Adv Radiat Oncol       Date:  2019-05-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.